Sushil Patel

Insider Reports History

Entity
Individual
Location
C/O Replimune Group, Inc., 500 Unicorn Park, Third Floor, Woburn, MA
Signature
/s/ Jack Anders, as Attorney-in-fact for Sushil Patel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sushil Patel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Chief Executive Officer, Director Common Stock 212K $1.37M $6.47 May 16, 2024 Direct
Revolution Medicines, Inc. Director Common Stock 19.9K $878K $44.00 Jul 9, 2024 Direct
Replimune Group, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 250K Apr 1, 2024 Direct
Revolution Medicines, Inc. Director Stock Option (Right to Buy) 32.5K Jul 9, 2024 Direct

Insider Reports Filed by Sushil Patel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVMD Revolution Medicines, Inc. Jul 9, 2024 3 -$58.6K 4 Jul 10, 2024 Director
RVMD Revolution Medicines, Inc. Jun 20, 2024 2 $0 4/A Jun 28, 2024 Director
RVMD Revolution Medicines, Inc. Jun 20, 2024 2 $0 4 Jun 24, 2024 Director
REPL Replimune Group, Inc. May 16, 2024 1 -$131K 4 May 20, 2024 Chief Executive Officer, Director
RVMD Revolution Medicines, Inc. Apr 10, 2024 3 -$43.5K 4 Apr 12, 2024 Director
REPL Replimune Group, Inc. Apr 1, 2024 2 $0 4 Apr 3, 2024 Chief Executive Officer, Director
REPL Replimune Group, Inc. Jun 13, 2023 2 -$137K 4 Jun 15, 2023 Chief Strategy Officer
RVMD Revolution Medicines, Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
REPL Replimune Group, Inc. May 16, 2023 1 -$281K 4 May 18, 2023 Chief Strategy Officer
REPL Replimune Group, Inc. Apr 1, 2023 2 $0 4 Apr 4, 2023 Chief Strategy Officer
RVMD Revolution Medicines, Inc. Jun 16, 2022 2 $0 4 Jun 17, 2022 Director
RVMD Revolution Medicines, Inc. Jun 16, 2022 0 $0 3 Jun 17, 2022 Director
REPL Replimune Group, Inc. May 16, 2022 1 -$156K 4 May 18, 2022 Chief Commercial Officer
REPL Replimune Group, Inc. Apr 1, 2022 2 $0 4 Apr 5, 2022 Chief Commercial Officer